Pricing Pressure Weighs on Munich Re Despite Record Q1, Shares Drop to 52-Week Low

Munich Re's management faces a packed schedule of investor meetings this week, but the market has already delivered its verdict: the future pricing outlook matters far more than the record profits just reported. Shares of the German reinsurance giant slid to a new 52-week low of €452.80 on Friday, extending a 30-day decline of 14.44% and bringing the year-to-date loss to 17.52%.

The next test arrives on June 2-3 at the Goldman Sachs 30th European Financials Conference in Zurich, where CFO Andrew Buchanan is scheduled to speak. The appearance follows a recent presentation at the Deutsche Bank Global Financial Services Conference in New York, where Munich Re America CEO Markus Winter addressed investors. With no new financial figures expected, the focus will fall squarely on how the management team assesses pricing conditions and underwriting discipline in the current cycle.

Operationally, the first quarter offered ample reason for confidence. Net profit surged 57% to €1.714 billion from €1.094 billion a year earlier, with an operating result of €2.230 billion. The return on equity reached 19.7%, and the solvency ratio stood at 292% — a figure that already incorporates a planned €2.25 billion share buyback program.

That record earnings power, however, is being overshadowed by a more worrying trend in the core reinsurance business. During the April renewal season, Munich Re's written premium volume fell to €2.0 billion, an 18.5% decline year-on-year. Risk-adjusted prices dropped 3.1% as the company walked away from business that did not meet its pricing and terms thresholds. Management has framed this as a matter of discipline, but the numbers have spooked investors who fear a broader softening of the market cycle.

Should investors sell immediately? Or is it worth buying Münchener Rück?

The July renewal window is now the critical near-term event. Munich Re expects that the still-favorable pricing environment and improvements in contract conditions will broadly hold. Whether that optimism withstands the April data will become clearer after the company's half-year report on August 7, followed by the third-quarter update on November 12.

Analysts have not yet turned bearish. Barclays reiterated its "Overweight" rating on May 26, citing the company's fundamental strength. The average price target among analysts sits at €564.57, implying roughly 25% upside from the current level. Technical support is seen at the €450 mark; a bounce from there could push shares back toward the 20-day moving average around €484.

The company's capital deployment program adds another layer of support. A first buyback tranche worth up to €900 million runs until August 2026, with the full program targeting €2.25 billion by the 2027 annual general meeting. Dividends also remain generous: €24.00 per share paid for the past financial year, with analysts projecting an increase to €25.65 for the current year.

Münchener Rück at a turning point? This analysis reveals what investors need to know now.

Yet for now, the market is fixated on the outlook rather than the rearview mirror. The shares are trading more than 25% below their 52-week high of €605.00, and an RSI of 73.9 in a sustained downtrend suggests selling momentum remains intact. Until the July renewal provides fresh evidence on pricing, the disconnect between strong profits and weak stock performance is likely to persist.

Ad

Münchener Rück Stock: New Analysis - 30 May

Fresh Münchener Rück information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Münchener Rück analysis...

en | DE0008430026 | PRICING | boerse | 69450080 |